Drug Approval | May 20, 2023
Granules India received ANDA approval for Venlafaxine ER capsules
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
These initiatives aim to improve access to healthcare for rare disease patients
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea
Apollo continues to invest in genomics technology and research for better patient care
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Subscribe To Our Newsletter & Stay Updated
